Literature DB >> 30816596

AP-1 and Mitf interact with NFATc1 to stimulate cathepsin K promoter activity in osteoclast precursors.

Manhui Pang1,2, Maria Rodríguez-Gonzalez1,2, Mireya Hernandez1,2, Claudia Carolina Recinos1,2, Kenneth Ladd Seldeen1,2, Bruce Robert Troen1,2.   

Abstract

Cathepsin K (CTSK) is a secreted protease that plays an essential role in osteoclastic bone resorption and osteoporotic bone loss. We have previously shown that activator protein 1 (AP-1) stimulates CTSK promoter activity and that proximal nuclear factor of activated T cells cytoplasmic 1 (NFATc1)-binding sites play a major role in the stimulation of CTSK gene expression by receptor activator of NFκB ligand (RANKL). In the present study, we have extended these observations and further dissected the effects of transcription factors involved in the regulation of CTSK gene expression. Our aim was to investigate the cooperative interplay among transcription factors AP-1, microphthalmia-associated transcription factor (Mitf), and NFATc1, and the consequent regulatory effects on CTSK transcription. Experiments were carried out in RAW 264.7 cells, which can be readily differentiated to osteoclasts upon RANKL stimulation. Our data show that AP-1, Mitf, and NFATc1 are capable of independently stimulating CTSK promoter activity. A combination of any two factors further enhances CTSK promoter activity, with the combination of AP-1 (c-fos/c-jun) and NFATc1 inducing the largest increase. We further identify a synergistic effect when all three factors cooperate intimately at the proximal promoter region, yielding maximal transcriptional upregulation of the CTSK promoter. RANKL induces temporal localization of AP-1 and NFATc1 to the CTSK promoter. These results suggest that the interaction of multiple transcription factors mediate a maximal response to RANKL-induced CTSK gene expression. Published 2019. This article is a U.S. Government work and is in the public domain in the USA.

Entities:  

Keywords:  bone resorption; cathepsin K (CTSK); fos; jun; osteoclastogenesis

Year:  2019        PMID: 30816596     DOI: 10.1002/jcb.28504

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  14 in total

Review 1.  Notch and the regulation of osteoclast differentiation and function.

Authors:  Jungeun Yu; Ernesto Canalis
Journal:  Bone       Date:  2020-06-08       Impact factor: 4.398

2.  Cholesterol inhibits autophagy in RANKL-induced osteoclast differentiation through activating the PI3K/AKT/mTOR signaling pathway.

Authors:  Chunyan Jiang; Yan Wang; Mengqi Zhang; Jin Xu
Journal:  Mol Biol Rep       Date:  2022-07-26       Impact factor: 2.742

3.  Letrozole Suppresses the Fusion of Osteoclast Precursors through Inhibition of p38-Mediated DC-STAMP Pathway.

Authors:  Hyung Joon Kim; Hwa-Sik Seong; YunJeong Choi; Soon Chul Heo; Yong-Deok Kim
Journal:  Int J Mol Sci       Date:  2020-11-09       Impact factor: 5.923

Review 4.  Role of Biomolecules in Osteoclasts and Their Therapeutic Potential for Osteoporosis.

Authors:  Xin Zhao; Suryaji Patil; Fang Xu; Xiao Lin; Airong Qian
Journal:  Biomolecules       Date:  2021-05-17

5.  Major vault protein (MVP) negatively regulates osteoclastogenesis via calcineurin-NFATc1 pathway inhibition.

Authors:  Lichan Yuan; Na Zhao; Junyi Wang; Yuying Liu; Li Meng; Shuyu Guo; Erik A C Wiemer; Qi Chen; Yelin Mao; Jingjing Ben; Junqing Ma
Journal:  Theranostics       Date:  2021-05-24       Impact factor: 11.556

6.  Inhibition of NFAM1 suppresses phospho-SAPK/JNK signaling during osteoclast differentiation and bone resorption.

Authors:  Purushoth Ethiraj; Ishraq A Haque; Anna K Alford; Wenyu Gou; Toolika Singh; Yuvaraj Sambandam; Jessica D Hathaway-Schrader; Sakamuri V Reddy
Journal:  J Cell Biochem       Date:  2021-07-06       Impact factor: 4.480

7.  The loss of STAT3 in mature osteoclasts has detrimental effects on bone structure.

Authors:  Rebecca K Davidson; Evan R Himes; Shinya Takigawa; Andy Chen; M Ryne Horn; Tomas Meijome; Joseph M Wallace; Melissa A Kacena; Hiroki Yokota; Andrew V Nguyen; Jiliang Li
Journal:  PLoS One       Date:  2020-07-30       Impact factor: 3.240

8.  Pregnenolone Inhibits Osteoclast Differentiation and Protects Against Lipopolysaccharide-Induced Inflammatory Bone Destruction and Ovariectomy-Induced Bone Loss.

Authors:  Xiaochen Sun; Chenxi Zhang; Huan Guo; Jiao Chen; Yali Tao; Fuxiao Wang; Xixi Lin; Qian Liu; Li Su; An Qin
Journal:  Front Pharmacol       Date:  2020-03-27       Impact factor: 5.810

9.  Fumitremorgin C Attenuates Osteoclast Formation and Function via Suppressing RANKL-Induced Signaling Pathways.

Authors:  Yu Yuan; Kai Chen; Xi Chen; Chao Wang; Heng Qiu; Zhen Cao; Dezhi Song; Youqiang Sun; Jianmin Guo; Jennifer Tickner; Jiake Xu; Jun Zou
Journal:  Front Pharmacol       Date:  2020-03-10       Impact factor: 5.810

10.  4-Acetylantroquinonol B Inhibits Osteoclastogenesis by Inhibiting the Autophagy Pathway in a Simulated Microgravity Model.

Authors:  Chia-Hsin Wu; Ching-Huei Ou; I-Chuan Yen; Shih-Yu Lee
Journal:  Int J Mol Sci       Date:  2020-09-22       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.